What mechanisms of action allow liraglutide to manage Type 2 diabetes and support weight loss, and how do these mechanisms compare to other treatments like metformin or insulin glargine
Retrieved from Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Differences in dosing schedules, potency, receptor affinity, and pharmacokinetic profiles help explain these variations in clinical outcomes
and Trulicity and Mounjaro (produced by Eli Lilly and Company)
If you experience severe, persistent abdominal pain while taking GLP-1 medications, stop taking the medication and seek urgent medical attention, as this could indicate pancreatitis or gallbladder disease
Finally, another layer of complexity is added when considering the evidence of a leaky bloodbrain barrier across several neuropsychiatric disorders 255 , which could further increase the brain penetrance of GLP-1RAs administered to people with such illnesses